References
Dixon M (1953) Biochem. J.55, 170–171.
Eid M, Evin G, Castro B, Menard J & Corvol P (1981) Biochem. J.197, 465–471.
Ford TF, Hermon-Taylor J & Grant DAW (1982a) Clin. Chim. Acta (submitted for publication).
Ford TF, Grant DAW, Austen BM & Hermon-Taylor J (1982b) Gastroenterology (submitted for publication).
Gisin BF (1973) Helv. Chim. Acta56, 1476–1479.
Kunimoto S, Aoyagi T, Morishima H, Takeuchi T & Umezawa H (1972) J. Antibiot.25, 251–255.
Lazar J, Orth H, Moehring J & Gross F (1972) Arch. Pharmacol.275, 114–118.
Merrifield RB (1963) J. Amer. Chem. Soc.85, 2149–2154.
Rich DH, Sun ETO & Ulm E (1980) J. Med. Chem.23, 27–33.
Umezawa H (1977) Acta. Biol. Med. Germ.36, 1899–1915.
Umezawa H, Aoyagi T, Morishima H, Matsuzaki M, Hamada H & Takeuchi T (1970) J. Antibiot.23, 259–262.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Austen, B.M., Ford, T.F., Grant, D.A.W. et al. Solid-phase synthesis of a soluble pepstatin derivative suitable for therapeutic use. Biosci Rep 2, 427–432 (1982). https://doi.org/10.1007/BF01119306
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01119306